Hepatitis bars China toddlers from kindergarten

BEIJING (Reuters) - A group of 101 mothers have written to China’s Communist Party leadership for help after their toddlers were denied kindergarten places for testing positive for hepatitis B.

China has passed laws in recent years reversing a ban on its 120-130 million hepatitis B carriers from the civil service, and banning companies from using the virus as an excuse to fire or not hire.

But activists and sufferers say discrimination and stigma fueled by ignorance remain widespread and a number of provincial governments still have laws banning carriers from kindergartens, despite minimal chances of infection from casual contact.

“Our children have already been unfortunate enough to be infected with hepatitis B, and yet to be treated with such discrimination they cannot receive a normal pre-school education,” said a transcript of the letter carried in the Beijing News on Thursday.

“How will this affect our children’s lives? How will stigmatization affect their character and their growing into adults? We dare not think,” it added.

Li Hua, a mother from coastal Shandong province, said the letter targeted Liu Yandong, a female member of China’s cabinet, the State Council, with an education portfolio.

“We thought of writing to Premier Wen Jiabao but thought he might be too busy… Then we thought of Liu Yandong because she is the only woman on the State Council… is possibly a mother herself, and can more deeply understand our feelings,” Li told Reuters by telephone.

Hepatitis B is usually transmitted from mother to child, but can be passed on through sex, blood transfusions and contaminated needles.

While older children and adults can flush out the virus, children under five usually end up carrying it for life. One in four are at risk of developing cirrhosis — scarring of the liver — or liver cancer later in life.  Continued…

Source

--------------------------------------------------------------------------------------------
Related Posts:


NEW YORK (Reuters Health) - Hepatitis A infections, usually transmitted via contaminated food, can cause debilitating illness, but protection afforded by the hepatitis A vaccine last more than a decade, a new study shows. In fact, antibodies against hepatitis A virus persist for up to 27 years after vaccination, report investigators from the Centers for Disease

Full Post: Hepatitis A vaccine gives long-lasting protection
--------------------------------------------------------------------------------------------

By Julie Steenhuysen CHICAGO (Reuters) - Doctors hope to be able to better predict which patients will respond to traditional treatment for the hepatitis C virus using a new method for identifying slight variances in the virus’ genetic makeup. U.S. researchers said on Monday that the technique may prove useful for other viruses such as HIV as

Full Post: Study may predict if hepatitis C drugs will work
--------------------------------------------------------------------------------------------

NEW YORK (Reuters Health) - In patients with advanced chronic hepatitis C infection who have not responded to prior therapy with the standard combination drug treatment — peginterferon and ribavirin — prolonged low-dose, or “maintenance” therapy does not reduce the rate of disease progression, new research shows. Patients who do not respond to initial antiviral therapy

Full Post: No benefit of extended hepatitis C therapy for some
--------------------------------------------------------------------------------------------

By Will Boggs, MD NEW YORK (Reuters Health) - Protection against hepatitis B appears to drop off in adolescents who got the hepatitis B vaccine beginning at birth, according to a new report. Dr. Stephanie R. Bialek from the US Centers for Disease Control and Prevention, Atlanta, Georgia, and colleagues evaluated the occurrence of breakthrough infections and

Full Post: Hepatitis B vaccine protection may wane in teens
--------------------------------------------------------------------------------------------

NEW YORK (Reuters Health) - The risk of a rare form of liver cancer called intrahepatic cholangiocarcinoma, which occurs in the bile ducts of the liver, is significantly elevated in individuals who are infected with hepatitis C virus (HCV), according to a large “case-control” study of US veterans. HCV-infected individuals are also at increased risk for

Full Post: Hepatitis C ups liver cancer risk, study confirms

Site Navigation

Most Read

Search